Zhaoke Biotechnology

Zhaoke Ophthalmology is a leading ophthalmic pharmaceutical company based in China, dedicated to the research, development, and commercialization of innovative and generic drugs for eye diseases. Spun off from Lee's Pharmaceutical, the company has built a comprehensive pipeline covering both front-of-the-eye and back-of-the-eye diseases, including dry eye, glaucoma, and wet age-related macular degeneration. Its lead candidate, a Cyclosporine A ophthalmic gel, is a potential best-in-class treatment for dry eye disease and recently received marketing approval in China. The company operates a state-of-the-art manufacturing facility in Guangzhou designed to meet international standards. Zhaoke Ophthalmology is listed on the Hong Kong Stock Exchange and continues to expand its portfolio through internal R&D and strategic global partnerships.